Meta Pixel

News and Announcements

Soar voted as one of the top ICO projects by ICO and blockchain leader INWARA

  • Published November 28, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Soar’s Telegram channel has hit 10,000 followers.
  • Soar was voted as one of the top ICO projects INWARA.
  • Soar was presented at the Fintech & Blockchain social night in Manhattan NY.

Soar are delighted to announce that they have been voted as one of the top ICO projects INWARA – a leader in ICO, blockchain and cryptocurrency data.

The Soar platform was presented by the Krypital Group at the Fintech & Blockchain social night in Manhattan NY.

The Fintech & Blockchain social night unites the exclusive and industry-leading professionals and experts of the blockchain field. This is the biggest social event after Consensus Invest 2018.

Soar are also pleased to announce that their Telegram channel has hit 10,000 followers and the public sale is still on.

 

About Soar

The Soar platform is designed to offer the international community a decentralised marketplace for high quality drone, aerial and satellite imagery, that connects customers with content creators in a secure, trustless and distributed community leveraging blockchain technology. Soar will very soon be the platform for all future mapping, imagery and geospatial information.

Hobbyist drone operators through to professional organisations will be able to monetise unused content in a marketplace driven by the free market forces of supply and demand.

Register Interest

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Join over 45,000+ sophisticated investors

Join Now